BackKaryopharm Therapeutics Overview
Karyopharm Therapeutics Inc

Karyopharm Therapeutics Target Price

Where could KPTI trade next? Consensus target price: $7.3.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.65

Average Target Price

$7.331028.4% upside

3 analysts in the last 4 months

High: $16 | Low: $3

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-31H.C. WainwrightRobert Burns$3361.6% upsideOpen
2026-07-31Robert W. Baird$3361.6% upsideOpen
2026-07-21RBC CapitalBrian Abrahams$162361.9% upsideOpen
2026-05-06H.C. Wainwright$131900.3% upsideOpen
2026-04-27Piper Sandler$162361.9% upsideOpen
2026-03-09UBS$284208.4% upsideOpen
2025-12-17Goldman Sachs$121746.4% upsideOpen
2025-12-17Piper Sandler$121746.4% upsideOpen
2025-11-04RBC CapitalBrian Abrahams$192823.5% upsideOpen
2025-10-13H.C. WainwrightRobert Burns$152208% upsideOpen
2025-10-09Robert W. Baird$213131.3% upsideOpen
2025-10-08Leerink Partners$6823.2% upsideOpen
2024-06-10RBC CapitalBrian Abrahams$3361.6% upsideOpen
2023-01-10Leerink Partners$5669.3% upsideOpen
2022-08-23Robert W. BairdCollen Kusy$142054.2% upsideOpen
2022-03-10RBC CapitalBrian Abrahams$81131% upsideOpen

Karyopharm Therapeutics (KPTI) FAQ

The latest target price for KPTI is $7.3. Investors often review this figure alongside Karyopharm Therapeutics's historical trend and sector peers before judging valuation or financial health.

Karyopharm Therapeutics trades near $0.65 while the consensus target sits at $7.3 (1028.4% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting KPTI's target price ($7.3), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Karyopharm Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.